Demonstrates the monetization of Colossal's core technology through specialized applications in industrial waste management.

First commercial spin-out of Colossal Biosciences addressing the global plastic crisis; success validates the parent company's business model.

Uses directed evolution and AI to break chemical bonds of plastic, addressing a massive global waste management market.

Spun out of Colossal, it addresses a multi-billion dollar plastic crisis with scalable microbial solutions and potential human health applications to eliminate microplastics.